Form D · Biotechnology

TOPERA, INC.

San Diego, CA · CIK 0001550054

Offering snapshot reported Mar 18, 2013 · SEC filing

Reported sold
$24.9M
Offering amount: $24.9M
Investors reported
38
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 4, 2013
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 18, 2013Initial$24,897,012No comparison38SEC filing
Oct 5, 2012Initial$3,770,000No comparison23SEC filing
May 15, 2012Initial$2,748,531No comparison20SEC filing

Offering details

Securities
Equity
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-193449

Source: Form D, filed Mar 18, 2013. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Rick Green Executive
Edward Kerslake Director, Executive
Thomas A Kordis Executive
Diane Marcou Executive
Sanjiv Narayan Director
Ruchir Sehra Director, Executive
Arthur Taylor Director, Executive
Art Taylor Director
Melissa Walker Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
6190 Cornerstone Court Suite 220
San Diego, CA, 92121